Haemonetics (HAE) net assets (shareholders' equity)

Net assets · fiscal 2026
$796.32M

Haemonetics (HAE) had net assets of $796.32M at the end of fiscal 2026 (March 31, 2026). That is 3.0% lower than the $820.84M of fiscal 2025. Figures as of 19 Nov 2026, 02:33 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Net assets, fiscal 2026
$796.32M
Change on fiscal 2025
−3.0%
Growth, 5 years
+1.7% a year
Growth, 10 years
+1.0% a year
Highest on record
$959.96Mfiscal 2024
Lowest on record
$539.88Mfiscal 2009
Fiscal years on record
182009–2026

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Haemonetics net assets (shareholders' equity), in more detail

Over the five fiscal years to 2026 net assets grew at a compound 1.7% a year; over ten years the rate was 1.0% a year. Across the 18 fiscal years on record (2009–2026), the highest was $959.96M in fiscal 2024 and the lowest $539.88M in fiscal 2009.

History · 18 fiscal years

Net assets by fiscal year

Haemonetics net assets (shareholders' equity), year by year

Haemonetics (HAE) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2026$796.32M 3.0% down
2025$820.84M 14.5% down
2024$959.96M 17.4% up
2023$818.00M 9.2% up
2022$749.42M 2.4% up
2021$731.67M 24.6% up
2020$587.11M 12.1% down
2019$667.87M 11.2% down
2018$752.43M 1.7% up
2017$739.61M 2.5% up
2016$721.57M 12.7% down
2015$826.12M 1.4% down
2014$837.89M 8.9% up
2013$769.18M 5.0% up
2012$732.63M 6.8% up
2011$686.14M 15.7% up
2010$593.12M 9.9% up
2009$539.88M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Haemonetics and comparable companies
CompanyNet assetsFiscal year
Hims & Hers Health HIMS$540.93M2025
PTC Therapeutics PTCT-$205.31M2025
Haemonetics HAE$796.32M2026
Erasca ERAS$325.17M2025
Concentra Group Holdings Parent CON$393.28M2025
Merit Medical Systems MMSI$1.58B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on HAE

Haemonetics, figure by figure

Haemonetics (HAE) overview: price, valuation and scorecardAll health care companies by market value

Haemonetics net assets (shareholders' equity): questions and answers

What are Haemonetics's net assets?

Haemonetics (HAE) had net assets of $796.32M at the end of fiscal 2026 (March 31, 2026). That is 3.0% lower than the $820.84M of fiscal 2025.

What is the growth rate of Haemonetics's net assets?

Over the five fiscal years to 2026 net assets grew at a compound 1.7% a year; over ten years the rate was 1.0% a year.

What are the highest and lowest net assets figures on record for Haemonetics?

Across the 18 fiscal years on record (2009–2026), the highest was $959.96M in fiscal 2024 and the lowest $539.88M in fiscal 2009.

How is Haemonetics's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Haemonetics it is on record here for 18 fiscal years, 2009 to 2026.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Haemonetics (HAE) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/HAE/net-assets

Underlying data: the company's filings with the SEC and Yahoo Finance.